A revocation to this notice was published on 1 November 2022, Notice No. 2022-go4681.

Notice Type
Departmental
Notice Title

Approval of a Lead Clinician to Provide Opioid Substitution Treatment Under Section 24A of the Misuse of Drugs Act 1975

Acting under delegated authority from the Minister of Health, I, Dr John Crawshaw:

  1. Revoke the approval of the Rata Alcohol and Other Drug Service and medical practitioner issued pursuant to section 24A(7)(a), (b) of the Misuse of Drugs Act 1975 on 29 July 2021 (as published in the New Zealand Gazette, 30 July 2021, Notice No. 2021-go3211); and
  2. Specify the Rata Alcohol and Other Drug Service as a service that may provide treatment with controlled drugs for people who are dependent on controlled drugs, pursuant to section 24A(7)(b) of the Misuse of Drugs Act 1975, at the following places:
    Grey Base Hospital
    High Street
    Greymouth 7805; and
    Buller Mental Health Service
    Derby Street
    Westport 7825; and
    Hokitika Health Centre
    Sewell Street
    Hokitika 7810.
  3. Pursuant to section 24A(7)(a) of the Misuse of Drugs Act 1975, specify that Dr Andrew Gin, as a medical practitioner, may:
    1. prescribe, administer or supply controlled drugs for the treatment of dependence as the lead clinician for Rata Alcohol and Other Drug Service;
    2. authorise in writing service/clinic medical practitioners as specified under subsection 24A(2)(b) to:
      1. prescribe, administer or supply controlled drugs for the treatment of dependence;
      2. authorise in writing general practitioners receiving clients from the Rata Alcohol and Other Drug Service as specified under section 24A(2)(b) of the Misuse of Drugs Act 1975; and
    3. authorise in writing general practitioners receiving clients from Rata Alcohol and Other Drug Service as specified under section 24A(2)(b) of the Misuse of Drugs Act 1975.

Conditions

  1. Controlled drugs may only be prescribed, administered or supplied to people who are or have been clients of Rata Alcohol and Other Drug Service.
  2. This approval expires on 1 November 2022.

Dated at Wellington this 15th day of October 2021.

Dr JOHN CRAWSHAW, Director of Mental Health, Mental Health and Addiction.